Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MSTLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Morgan Stanley's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Morgan Stanley's regulatory disclosures and financial reporting.
Morgan Stanley Co-President Daniel A. Simkowitz reported a sale of company stock. On January 30, 2026, he sold 32,968 shares of Morgan Stanley common stock in an open-market transaction at a weighted average price of $182.6108, with individual trade prices ranging from $182.06 to $183.05.
Following this sale, he beneficially owns 357,342.406 shares of Morgan Stanley common stock directly and 1,794.818 shares indirectly through a 401(k) plan.
Morgan Stanley filed a Form 144 indicating that an affiliate plans to sell 32,968 shares of its common stock through Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of
The shares were acquired on
Morgan Stanley Chief Financial Officer Sharon Yeshaya reported a sale of common stock in the company. On January 20, 2026, Yeshaya sold 15,838 shares of Morgan Stanley common stock in an open-market transaction, reported with code “S” for a sale. The weighted average sale price was $185.7669 per share, with individual trades executed between $185.67 and $185.98 per share.
After this transaction, Yeshaya beneficially owned 135,304.336 shares of Morgan Stanley common stock in direct ownership. The filing notes that detailed price and size information for each individual trade in the reported price range is available upon request from Morgan Stanley, its security holders, or the SEC staff.
Morgan Stanley Chief Risk Officer Charles A. Smith reported selling common stock in a recent insider transaction. On January 20, 2026, he sold 8,500 shares of Morgan Stanley common stock at a weighted average price of $182.0807 per share. The filing notes that these shares were sold in multiple trades at prices ranging from $182.0401 to $182.1301.
After this sale, Smith reported owning 119,127.619 shares of Morgan Stanley common stock directly. He also reported an indirect holding of 5,494.73 shares through a 401(k) plan. The filing states that detailed trade-by-trade pricing information is available upon request from Morgan Stanley, its security holders, or the SEC staff.
Morgan Stanley Co-President Andrew M. Saperstein reported multiple open-market sales of the company’s common stock on January 20, 2026. The Form 4 shows several separate transactions, each coded "S" for sale, with block sizes ranging from 500 shares to 11,430 shares at reported weighted average prices such as $181.8518, $182.6338, $184.1265, $184.9381, $185.9112, and $186.5960 per share. After these transactions, Saperstein directly beneficially owned 280,480.994 Morgan Stanley common shares.
For each block, the filing notes that the reported price is a weighted average of multiple trades, with actual execution prices ranging from $181.34 to $186.65. The reporting person undertakes to provide full trade-by-trade details within these ranges to Morgan Stanley, its security holders, or the SEC staff upon request.
Morgan Stanley Head of Technology & Operations Michael A. Pizzi reported a sale of Morgan Stanley common stock. On January 20, 2026, he sold 20,000 shares of common stock at a price of $184.55 per share, according to the Form 4 filing. After this transaction, he beneficially owned 127,872.293 shares of Morgan Stanley common stock, held in direct ownership. The filing reflects this as a non-derivative transaction coded as a sale and shows no derivative securities activity.
Morgan Stanley director files amended insider trading report correcting prior gift details. The amended Form 4 now shows that on 01/20/2026 a bona fide gift of 542 shares of Morgan Stanley common stock was made at a reported price of $0, reflecting that this was a gift rather than an open-market sale. Following this transaction, the reporting person directly beneficially owns 11,845.004 shares of Morgan Stanley common stock. The amendment updates the previously filed report from 01/16/2026 to correct the transaction date, the number of shares transferred, and the post-transaction holdings.
Morgan Stanley Chief Legal/Admin Officer Eric F. Grossman reported two transactions in the company’s common stock dated January 20, 2026. He sold 21,555 shares at a weighted average price of
On the same date, Grossman also reported a transaction coded "G" for 2,495 shares of common stock at a reported price of
Morgan Stanley’s Chief Client Officer, Crawley Mandell, reported selling a total of 7,860 shares of the company’s common stock on January 20, 2026. The sales were executed in several market transactions, with weighted average prices ranging from about
After these transactions, Mandell directly owned 68,788.495 shares of Morgan Stanley common stock. All reported positions are non-derivative common stock, and there were no derivative security transactions disclosed in this filing.
A holder of Morgan Stanley (MS) common stock has filed a notice of proposed sale under Rule 144. The filing covers the planned sale of 7,860 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 01/20/2026, to be executed on the NYSE, with an indicated aggregate market value of $1,441,879.27. As context, the filing notes 1,589,309,311 common shares outstanding.
The securities to be sold were acquired on 01/16/2026 directly from the issuer as employee stock unit awards, with that same date listed as the payment date and the amount acquired matching the proposed sale of 7,860 shares. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.